{"id":"https://openalex.org/W4200548613","doi":"https://doi.org/10.3389/fphar.2021.744532","title":"Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)","display_name":"Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)","publication_year":2021,"publication_date":"2021-12-16","ids":{"openalex":"https://openalex.org/W4200548613","doi":"https://doi.org/10.3389/fphar.2021.744532","pmid":"https://pubmed.ncbi.nlm.nih.gov/34975469","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8717920"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.744532","doi":"https://doi.org/10.3389/fphar.2021.744532","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.744532","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2021.744532","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033643112","display_name":"Annemieke M Aartsma-Rus","orcid":"https://orcid.org/0000-0003-1565-654X","observed_orcids":["https://orcid.org/0000-0003-1565-654X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Annemieke Aartsma-Rus","raw_affiliation_strings":["Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061401059","display_name":"Marc Marie Dooms","orcid":"https://orcid.org/0000-0002-1709-087X","observed_orcids":["https://orcid.org/0000-0002-1709-087X"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marc Dooms","raw_affiliation_strings":["University Hospitals Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065877949","display_name":"Yann Le Cam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285072804","display_name":"European Organisation for Rare Diseases","ror":"https://ror.org/019w4mg02","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I1285072804"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yann Le Cam","raw_affiliation_strings":["EURORDIS, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EURORDIS, Brussels, Belgium","institution_ids":["https://openalex.org/I1285072804"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5033643112"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":7.0622,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.96826046,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"12","issue":null,"first_page":"744532","last_page":"744532"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.9340000152587891},{"id":"https://openalex.org/keywords/orphan-drug-incentives","display_name":"orphan drug incentives","score":0.8460000157356262},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.9909999966621399},{"id":"https://openalex.org/keywords/orphan-drug-policy","display_name":"orphan drug policy","score":0.6779999732971191},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.46299999952316284},{"id":"https://openalex.org/keywords/financial-incentives","display_name":"financial incentives","score":0.6389999985694885},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.8450000286102295},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.6970000267028809},{"id":"https://openalex.org/keywords/pharmaceutical-research-and-development","display_name":"pharmaceutical R&D","score":0.5450000166893005},{"id":"https://openalex.org/keywords/eu-policy","display_name":"European Union policy","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.7064422369003296},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.6778148412704468},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.46479174494743347},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4469951391220093},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.44287508726119995},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.44283249974250793},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.4324701428413391},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.42863929271698},{"id":"https://openalex.org/C201305675","wikidata":"https://www.wikidata.org/wiki/Q852998","display_name":"Stakeholder","level":2,"score":0.411574125289917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37603890895843506},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.33915379643440247},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.2812376618385315},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.2562047243118286},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.15802261233329773},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.13070625066757202},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":8,"locations":[{"id":"doi:10.3389/fphar.2021.744532","doi":"https://doi.org/10.3389/fphar.2021.744532","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.744532","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8717920","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8717920","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:34975469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34975469","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:alma.31UKB_LEU:9940749110402711","doi":null,"is_oa":true,"landing_page_url":"https://scholarlypublications.universiteitleiden.nl/handle/1887/3256600","pdf_url":"https://scholarlypublications.universiteitleiden.nl/download/1887/3256600/1?col=81522199330002711","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:lirias2repo.kuleuven.be:20.500.12942/749553","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/20.500.12942/749553","pdf_url":"https://lirias.kuleuven.be/retrieve/f8eecab5-61ef-49e4-9bab-d3facc2e989a","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers In Pharmacology, vol. 12, Art.No. ARTN 744532","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:lumc:oai:scholarlypublications.universiteitleiden.nl:item_3256600","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1887/3256600","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, 12. FRONTIERS MEDIA SA","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:58defd8c921d4261a720173a706bf39b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/58defd8c921d4261a720173a706bf39b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:item_3256600","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1887/3256600","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology","raw_type":"Article / Letter to editor"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.744532","doi":"https://doi.org/10.3389/fphar.2021.744532","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.744532","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"},{"id":"https://openalex.org/F4320309888","display_name":"Chiesi Farmaceutici","ror":"https://ror.org/0511bn634"},{"id":"https://openalex.org/F4320314126","display_name":"PTC Therapeutics","ror":"https://ror.org/03jz67a83"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1999697554","https://openalex.org/W2045417842","https://openalex.org/W2212454316","https://openalex.org/W2302501749","https://openalex.org/W2347008639","https://openalex.org/W2520382356","https://openalex.org/W2536642772","https://openalex.org/W2743415974","https://openalex.org/W2761623236","https://openalex.org/W2769892380","https://openalex.org/W2792833459","https://openalex.org/W2901295411","https://openalex.org/W2906623530","https://openalex.org/W2949885556","https://openalex.org/W2973267506","https://openalex.org/W2977575312","https://openalex.org/W2994844251","https://openalex.org/W2995381955","https://openalex.org/W2996041071","https://openalex.org/W3017382633","https://openalex.org/W4299584209"],"related_works":["https://openalex.org/W7171850741","https://openalex.org/W2916774518","https://openalex.org/W4388639352","https://openalex.org/W4293030616","https://openalex.org/W2062958372","https://openalex.org/W4200602822","https://openalex.org/W2460054967","https://openalex.org/W1234271775","https://openalex.org/W2118432205","https://openalex.org/W4388639337"],"abstract_inverted_index":{"Today":[0],"policy":[1,9,57,62,106,145,224,233],"makers":[2,63],"face":[3],"the":[4,74,86,100,116,130,134,153,168,179,185,192,205,208,220,223,237],"challenge":[5],"to":[6,21,29,55,59,64,120,151,166,177,190],"devise":[7],"a":[8,110,144,214,229],"framework":[10,225],"that":[11,102,143,219,235],"improves":[12],"orphan":[13],"medicinal":[14],"product":[15],"(OMP)":[16],"development":[17,132,242],"by":[18],"creating":[19],"incentives":[20,172],"deliver":[22],"treatments":[23,34,36],"where":[24,35],"there":[25],"are":[26],"none":[27],"and":[28,32,92,159,173,182,194,198,228],"authorize":[30],"innovative":[31],"transformative":[33],"already":[37],"exist.":[38],"The":[39,68,95],"European":[40],"Expert":[41,49,136,210],"Group":[42,137,211],"on":[43,99],"Orphan":[44],"Drug":[45],"Incentives":[46],"(hereafter,":[47],"OD":[48,135,209],"Group)":[50],"came":[51],"together":[52,71],"in":[53,109,243],"2020":[54],"develop":[56],"proposals":[58,234],"facilitate":[60],"EU":[61],"meet":[65],"this":[66],"challenge.":[67],"group":[69],"brings":[70],"representatives":[72],"of":[73,85,124,162,170,184,196,207,216,222,231,240],"broad":[75],"rare":[76,89,125],"disease":[77,90,126],"community,":[78,88],"including":[79],"researchers,":[80],"academia,":[81],"patient":[82],"representatives,":[83],"members":[84],"investor":[87],"companies":[91],"trade":[93],"associations.":[94],"group's":[96],"work":[97,212],"builds":[98],"recognition":[101],"only":[103],"an":[104],"ambitious":[105],"agenda":[107],"developed":[108],"multi-stakeholder":[111],"setting":[112],"can":[113],"bring":[114],"about":[115],"quantum":[117],"leap":[118],"needed":[119],"address":[121,236],"unmet":[122],"needs":[123,142,239],"patients":[127],"today.":[128,245],"Along":[129],"OMP":[131,241],"path,":[133],"has":[138],"identified":[139],"four":[140],"main":[141,238],"revision":[146,221],"should":[147,226],"address:":[148],"1)":[149],"Need":[150,165,176,189],"improve":[152,167,178,191],"R&D":[154],"ecosystem":[155],"for":[156,200],"basic":[157],"research":[158],"company":[160],"take-up":[161],"development.":[163],"2)":[164],"system":[169],"financial":[171],"rewards.":[174],"3)":[175],"flexibility,":[180],"predictability":[181,195],"speed":[183],"regulatory":[186],"pathway.":[187],"4)":[188],"coherence":[193],"demand":[197],"pricing":[199],"OMPs.":[201],"This":[202],"article":[203],"presents":[204],"results":[206],"as":[213],"set":[215,230],"guiding":[217],"principles":[218],"follow":[227],"14":[232],"Europe":[244]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":11}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-12-31T00:00:00"}